M2-like TAMs promote tumor progression by secreting pro-angiogenic factors such as VEGF and PDGF, activating vascular endothelial growth factor receptor 2 (VEGFR-2) on endothelial cells to drive angiogenesis. Here, VEGFA is linked to neoplasm.